Ziftomenib
KO-MEN-017
Phase 3 small_molecule active
Quick answer
Ziftomenib for Acute Myeloid Leukemia (AML) is a Phase 3 program (small_molecule) at Kura Oncology with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Kura Oncology
- Indication
- Acute Myeloid Leukemia (AML)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active